The Early Development Leader (EDL) is a high-responsibility, strategic role, critical for developing the vision and trajectory for a medicine that maximizes its opportunity for GSK and benefit for patients.
The EDL is the single point of accountability to lead the development of a medicine from initiation of Lead Optimization through Proof of Concept (PoC), defining the criteria necessary to identify and progress game-changing medicines through creative and innovative experimental design.
By working with various stakeholders across R&D, the EDL obtains and manages associated resources and delivers evidence in line with the strategic vision and organizational strategy to support progression beyond PoC for a clearly differentiated medicine.
The EDL’s accountability and key responsibilities include but are not limited to:
Leadership of the Early Development Strategy
1. Contributes to and establishes the development strategy to support the Medicine Profile (MP)
2. Secures input and alignment from late-stage Development, Commercial and Medical
3. Ensures asset development strategy is kept current, as internal priorities shift and the external landscape changes
Matrix Leadership of the Early Development Team (EDT)
4. Leads the multi-disciplinary Early Development matrix team and owns the performance of the EDT
5. Makes clear and timely evidence-based accelerate/go/no-go decisions in line with the strategy
6. Ensures excellence in execution of all governance processes
7. Prioritizes activities and manages the early development plan to meet budget constraints
8. Ensures team accountabilities, including study oversight, pharmacovigilance, scientific engagement and promotional practices are in line with the development strategy and GSK expectations
9. Delivers the package of evidence that supports the MP for a medicine of value
10. Models GSK values and leadership expectations
Business Partnering beyond the EDT
11. Provides significant input in selecting members of the EDT, in consultation with the Functional Line leaders, supporting differentiated development for team members
12. Strategically partners with Functional Line Heads to ensure alignment with organizational priorities and to maximize the asset’s portfolio options including developing multiple indications
13. Provides key support to the Project Team (PT) in the lead up to the Commit to Lead Optimization milestone and to the Medicines Development Team (MDT) following achievement of PoC to ensure end-to-end alignment on the drug development strategy
14. Works closely with the Project Leader (PL) and Medicine Development Leader (MDL) to ensure smooth transitions from the PL ahead of Commit to Lead Optimization and to the MDL upon achieving PoC
15. Advanced degree such as PhD, MD, PharmD, MBA or equivalent is required
16. Minimum of 10 years drug development experience in the pharmaceutical industry - Must demonstrate deep drug development expertise
17. Proven ability to think and plan strategically and to work with members of other functions within a matrix environment utilizing well-developed leadership and stakeholder management skills
18. Understands the relevance of early-stage questions, including tools and methodologies for addressing the questions: “learning about the asset” and appreciates limitations and strengths of the pre-clinical setting
19. Demonstrates thorough translational understanding (pre-clinical/clinical)
20. Pre-clinical and clinical development experience (end-to-end knowledge)
21. Experience or expertise in Immuno-Inflammation, Respiratory, Hepatology, GI, Renal, Connective Tissue or neurodegenerative diseases areas
22. Experience as a matrix leader able to work across technical disciplines and integrate requirements from matrix partners into a coherent evidence-generation and forward plan
23. Experience or clear familiarity / understanding of the attributes of early clinical development and importance of clinical pharmacology, modelling & simulation and statistics
24. Experience gathering early commercial insights and awareness of the impact of external factors, e.g., public policy, competitor landscape
25. Prior significant pre-clinical and clinical expertise in drug development with an emphasis on earlier stage clinical development and translational medicine
26. Expertise/knowledge in translational medicine/experimental medicine design and management
27. Strong understanding of options for regulatory pathways, Life Cycle Management and sequencing of indications
28. Knowledge of manufacturing compliance and regulatory requirements
Please visit to learn more about the comprehensive benefits program GSK offers US employees.
Why GSK?
Uniting science, technology and talent to get ahead of disease together.
GSK is a global biopharma company with a purpose to unite science, technology and talent to get ahead of disease together. We aim to positively impact the health of 2.5 billion people by the end of the decade, as a successful, growing company where people can thrive. We get ahead of disease by preventing and treating it with innovation in specialty medicines and vaccines. We focus on four therapeutic areas: respiratory, immunology and inflammation; oncology; HIV; and infectious diseases – to impact health at scale.
People and patients around the world count on the medicines and vaccines we make, so we’re committed to creating an environment where our people can thrive and focus on what matters most. Our culture of being ambitious for patients, accountable for impact and doing the right thing is the foundation for how, together, we deliver for patients, shareholders and our people.
GSK is an Equal Opportunity Employer. This ensures that all qualified applicants will receive equal consideration for employment without regard to race, color, religion, sex (including pregnancy, gender identity, and sexual orientation), parental status, national origin, age, disability, genetic information (including family medical history), military service or any basis prohibited under federal, state or local law.
Important notice to Employment businesses/ Agencies
GSK does not accept referrals from employment businesses and/or employment agencies in respect of the vacancies posted on this site. All employment businesses/agencies are required to contact GSK's commercial and general procurement/human resources department to obtain prior written authorization before referring any candidates to GSK. The obtaining of prior written authorization is a condition precedent to any agreement (verbal or written) between the employment business/ agency and GSK. In the absence of such written authorization being obtained any actions undertaken by the employment business/agency shall be deemed to have been performed without the consent or contractual agreement of GSK.